Integrated Diagnostics Holdings PLC
LSE:IDHC
Intrinsic Value
Integrated Diagnostics Holdings Plc engages in the provision of diagnostics services including pathology and molecular diagnostics, genetics testing and basic radiology to patients and other laborator... [ Read More ]
The intrinsic value of one
IDHC
stock under the Base Case scenario is
0.51
USD.
Compared to the current market price of 0.34 USD,
Integrated Diagnostics Holdings PLC
is
Undervalued by 33%.
IDHC could be a value trap.A value trap occurs when a stock looks inexpensive based on fundamental analysis but fails to reach its intrinsic valuation over time, often due to underlying issues not reflected in quantitative data.
Scrutinize beyond numbers; assess long-term potential.
Integrated Diagnostics Holdings PLC's market capitalization is 204m USD.
IDHC stock price is 0.34 USD.
IDHC stock price (0.34 USD) is 33% less than its Intrinsic Value (0.51 USD).
IDHC.
IDHC's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 11%.
IDHC's Revenue has grown by 14% over the past 12 months.
IDHC's ROE (Return on Equity) has decreased in the last 3 years from 26% to 21%.
IDHC has positive Net Debt. This means that the company has more debt (959m EGP) than cash and short-term investments (861m EGP).
IDHC's ROE (Return on Equity) for the past 12 months is positive and is equal to 21%.
IDHC has positive Net Income for the last twelve months.
IDHC's ROIC (Return on Invested Capital) has decreased in the last 3 years from 20% to 11%.
IDHC's short-term assets (2B EGP) exceed its short-term liabilties (1B EGP).
IDHC's Revenue has been growing by 16% per year for the last 3 years.
IDHC's Revenue is forecast to grow at a rate of 27% per year over the next 3 years.
IDHC has positive Operating Income for the last twelve months.
IDHC's long-term assets (6B EGP) exceed its long-term liabilties (3B EGP).
IDHC has positive three-year average ROIC (Return on Invested Capital): 23%. The company is efficient at using invested capital to generate operating income.
IDHC has positive Gross Profit for the last twelve months.
IDHC has positive Free Cash Flow for the last twelve months.
IDHC has very high three-year average ROE (Return on Equity): 35%. The company is very efficient at transforming stockholders' equity into net income.
IDHC's Altman Z-Score is very low and is equal to 1.41.
IDHC's D/E (Debt to Equity) is very low and is equal to 0.36.
IDHC generates enough operating income (768m EGP) to cover interest payments on its debt (138m EGP).
Valuation Backtest
Integrated Diagnostics Holdings PLC
Run backtest to discover the historical profit from buying and selling
IDHC
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Integrated Diagnostics Holdings PLC
Balance Sheet Decomposition
Integrated Diagnostics Holdings PLC
| Current Assets | 2B |
| Cash & Short-Term Investments | 860.5m |
| Receivables | 685.1m |
| Other Current Assets | 416.8m |
| Non-Current Assets | 3.8B |
| PP&E | 2.1B |
| Intangibles | 1.7B |
| Current Liabilities | 1.3B |
| Accounts Payable | 271.7m |
| Accrued Liabilities | 187.4m |
| Other Current Liabilities | 816.3m |
| Non-Current Liabilities | 1.8B |
| Long-Term Debt | 958.8m |
| Other Non-Current Liabilities | 857.2m |
Earnings Waterfall
Integrated Diagnostics Holdings PLC
|
Revenue
|
4.1B
EGP
|
|
Cost of Revenue
|
-2.6B
EGP
|
|
Gross Profit
|
1.5B
EGP
|
|
Operating Expenses
|
-756.8m
EGP
|
|
Operating Income
|
767.6m
EGP
|
|
Other Expenses
|
-257.3m
EGP
|
|
Net Income
|
510.3m
EGP
|
Free Cash Flow Analysis
Integrated Diagnostics Holdings PLC
IDHC Profitability Score
Profitability Due Diligence
Integrated Diagnostics Holdings PLC's profitability score is 68/100. The higher the profitability score, the more profitable the company is.
Score
Integrated Diagnostics Holdings PLC's profitability score is 68/100. The higher the profitability score, the more profitable the company is.
IDHC Solvency Score
Solvency Due Diligence
Integrated Diagnostics Holdings PLC's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Score
Integrated Diagnostics Holdings PLC's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IDHC Price Targets Summary
Integrated Diagnostics Holdings PLC
Shareholder Return
IDHC Price
Integrated Diagnostics Holdings PLC
| Average Annual Return | -5.65% |
| Standard Deviation of Annual Returns | 30.67% |
| Max Drawdown | -76% |
| Market Capitalization | 204m USD |
| Shares Outstanding | 600 000 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Integrated Diagnostics Holdings PLC
Country
Industry
Market Cap
Dividend Yield
Description
Integrated Diagnostics Holdings Plc engages in the provision of diagnostics services including pathology and molecular diagnostics, genetics testing and basic radiology to patients and other laboratories. The firm operates in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The company is engaged in offering services in immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology and radiology. Its brands include Al Borg, Al Borg Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar Sudan (both in Sudan), and Echo-Lab (Nigeria). The company operates in approximately 507 branches. IDH offers 2,000 diagnostic pathology tests ranging from routine to advanced. Its common tests include those for cholesterol, diabetes, pregnancy, and substance abuse. Through Al Borg Scan, it offers a range of radiology services, including but not limited to magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, x-ray, mammograms, cath lab facilities, and positron emission tomography-computed tomography (PET-CT).
Contact
IPO
Employees
Officers
The intrinsic value of one
IDHC
stock under the Base Case scenario is
0.51
USD.
Compared to the current market price of 0.34 USD,
Integrated Diagnostics Holdings PLC
is
Undervalued by 33%.
You don't have any saved screeners yet
